EARLY SUPPRESSION OF SIV REPLICATION BY CD8+ NEF-SPECIFIC CYTOTOXIC T-CELLS IN VACCINATED MACAQUES

被引:182
作者
GALLIMORE, A
CRANAGE, M
COOK, N
ALMOND, N
BOOTMAN, J
RUD, E
SILVERA, P
DENNIS, M
CORCORAN, T
STOTT, J
MCMICHAEL, A
GOTCH, F
机构
[1] JOHN RADCLIFFE HOSP,INST MOLEC MED,MOLEC IMMUNOL GRP,OXFORD OX3 9DU,ENGLAND
[2] CTR APPL MICROBIOL & RES,SALISBURY SP4 0JG,WILTS,ENGLAND
[3] NATL INST BIOL STAND & CONTROLS,AIDS COLLABORATING CTR,POTTERS BAR EN6 3QG,HERTS,ENGLAND
[4] NATL INST BIOL STAND & CONTROLS,DIV IMMUNOBIOL,POTTERS BAR EN6 3QG,HERTS,ENGLAND
[5] DEPT HLTH & WELF,LAB CTR DIS CONTROL,BUR HIV AIDS,OTTAWA,ON K1A 0L2,CANADA
关键词
D O I
10.1038/nm1195-1167
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In order to develop a successful subunit vaccine against infection with the human immunodeficiency virus (HIV), protective immune effector functions must be identified. Until now, there has been only indirect evidence that HIV-specific cytotoxic T lymphocytes (CTLs) fulfill this role. Using the macaque simian immunodeficiency virus (SIV) model, the protective potential of nef-specific CTLs, stimulated by vaccination, was examined in animals challenged with a high intravenous dose of the pathogenic simian immunodeficiency virus, SIVmac251(32H)(pJ5). An inverse correlation was found between the vaccine-induced nef-specific CTL precursor frequency and virus load measured after challenge. In addition, the early decline in viraemia, observed in both vaccinated and unvaccinated control animals was associated with the development of virus-specific CTL activity and not with the presence of virus-specific neutralizing; antibodies. The results imply that vaccines that stimulate strong CTL responses could protect against HIV infection.
引用
收藏
页码:1167 / 1173
页数:7
相关论文
共 39 条
[1]   HIV-1 RECOMBINANT POXVIRUS VACCINE INDUCES CROSS-PROTECTION AGAINST HIV-2 CHALLENGE IN RHESUS MACAQUES [J].
ABIMIKU, AG ;
FRANCHINI, G ;
TARTAGLIA, J ;
ALDRICH, K ;
MYAGKIKH, M ;
MARKHAM, PD ;
CHONG, PL ;
KLEIN, M ;
KIENY, MP ;
PAOLETTI, E ;
GALLO, RC ;
ROBERTGUROFF, M .
NATURE MEDICINE, 1995, 1 (04) :321-329
[2]   GENERATION OF DIGOXIGENIN-LABELED DOUBLE-STRANDED AND SINGLE-STRANDED PROBES USING THE POLYMERASE CHAIN-REACTION [J].
AN, SF ;
FRANKLIN, D ;
FLEMING, KA .
MOLECULAR AND CELLULAR PROBES, 1992, 6 (03) :193-200
[3]   HIV-2-SPECIFIC CYTOTOXIC T-LYMPHOCYTE ACTIVITY IS INVERSELY RELATED TO PROVIRAL LOAD [J].
ARIYOSHI, K ;
CHAM, F ;
BERRY, N ;
JAFFAR, S ;
SABALLY, S ;
CORRAH, T ;
WHITTLE, H .
AIDS, 1995, 9 (06) :555-559
[4]   INDUCTION OF PROTECTIVE CYTOTOXIC T-CELLS WITH VIRAL-PROTEINS [J].
BACHMANN, MF ;
KUNDIG, TM ;
FREER, G ;
LI, Y ;
KANG, CY ;
BISHOP, DH ;
HENGARTNER, H ;
ZINKERNAGEL, RM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (09) :2228-2236
[5]  
BANGHAM CRM, 1989, T CELLS
[6]   AN INTERNATIONAL COLLABORATIVE STUDY TO ASSESS A SET OF REFERENCE REAGENTS FOR HIV-1 PCR [J].
BOOTMAN, JS ;
KITCHIN, PA .
JOURNAL OF VIROLOGICAL METHODS, 1992, 37 (01) :23-42
[7]   REFERENCE PREPARATIONS IN THE STANDARDIZATION OF HIV-1 PCR - AN INTERNATIONAL COLLABORATIVE STUDY [J].
BOOTMAN, JS ;
KITCHIN, PA .
JOURNAL OF VIROLOGICAL METHODS, 1994, 49 (01) :1-8
[8]  
BOURGAULT I, 1994, J IMMUNOL, V152, P2530
[9]  
BRINCHMANN JE, 1990, J IMMUNOL, V144, P2961
[10]   VIROLOGICAL AND IMMUNOLOGICAL CHARACTERIZATION OF LONG-TERM SURVIVORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
CAO, YZ ;
QIN, LM ;
ZHANG, LQ ;
SAFRIT, J ;
HO, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (04) :201-208